ABSTRACT-Tranilast, an anti-allergic drug that inhibits the release of substances such as histamine and prostaglandins from mast cells, has been reported to improve keloids and hypertrophic scars which originate from the abnormal proliferation and excessive collagen accumulation of fibroblasts. It has been considered that various chemical mediators produced by inflammatory cells play important roles in the development of keloids and hypertrophic scars. We therefore studied the effect of tranilast on the release of chemical mediators including transforming growth factor (TGF)-/31, interleukin (IL)-1/3 and prostaglandin (PG) E2 which are produced by the human monocytes-macrophages, and estimated whether these mediators induce collagen synthesis and cell proliferation of normal skin fibroblasts. Tra nilast inhibited the release of TGF-,81, IL-1,8 and PGE2 from the human monocytes-macrophages. TGF ,81 (25 -200 pM) enhanced the collagen synthesis by fibroblasts. IL-1 (0.1-1 U/ml) increased the prolif eration and conversely decreased the collagen synthesis. PGE2 (2,ug/ml) enhanced the collagen synthe sis. These results suggest that tranilast suppresses collagen synthesis by fibroblasts through inhibiting TGF-,81 and PGE2 production and cell proliferation by fibroblasts through inhibiting IL-1 production by inflammatory cells such as macrophages.
A n e w fluorescent calix[4]arene 2 has been synthesized as an intramolecular excimer-forming Na+ sensor which shows a change in fluorescent characteristics specifically upon complexation w i t h Na+.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.